<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: In patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), severe neurological syndromes indicating central, peripheral or autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system involvement are frequently seen </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) increases the risk of <z:mp ids='MP_0008912'>nervous</z:mp> system involvement </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the study was to assess neurological manifestations occurring in patients with SLE and to evaluate their association with APS </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: One hundred thirty-seven patients (123 women and 14 men) with SLE were studied </plain></SENT>
<SENT sid="4" pm="."><plain>Fifty out of 137 patients (43 women and 7 men) were diagnosed with APS </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent full neurological examination and diagnostics </plain></SENT>
<SENT sid="6" pm="."><plain>Neurological syndromes were classified according to the standardized American College of Rheumatology (ACR) nomenclature </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Neurological syndromes were found in 89 cases out of 137 admitted SLE patients (64.96%) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002315'>Headache</z:hpo> was present in 52 patients (37.96%), <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo> in 17 (12.41%), cerebrovascular disease in 13 (9.49%), <z:hpo ids='HP_0001250'>seizures</z:hpo> in 10 (7.3%), <z:e sem="disease" ids="C0010266" disease_type="Disease or Syndrome" abbrv="">cranial neuropathy</z:e> in 5 (3.65%), demyelinating syndrome in 5 (3.65%), <z:hpo ids='HP_0009831'>mononeuropathy</z:hpo> in 3 (2.19%), <z:hpo ids='HP_0100022'>movement disorder</z:hpo> in 3 (2.19%), and aseptic <z:hpo ids='HP_0001287'>meningitis</z:hpo> in 2 patients (1.46%) </plain></SENT>
<SENT sid="9" pm="."><plain>Our study indicated that 78% of patients with APS showed <z:mp ids='MP_0008912'>nervous</z:mp> system involvement as compared with 57.47% of SLE patients without APS (p=0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Neurological syndromes occurring most frequently in SLE patients include <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo> and cerebrovascular diseases </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> increases the risk of <z:mp ids='MP_0008912'>nervous</z:mp> system involvement </plain></SENT>
<SENT sid="12" pm="."><plain>We found that APS was strongly associated with neurological manifestations and in particular with cerebrovascular diseases and <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
</text></document>